Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2005
11/30/2005EP1599453A1 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis
11/30/2005EP1599452A1 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivatives and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis
11/30/2005EP1599443A1 Cycloalkyl-substituted alkanoic acid derivatives, methods for the production thereof, and use thereof as a medicament
11/30/2005EP1599432A1 Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them
11/30/2005EP1599233A2 Sterilization of beclomethasone drug particles for pulmonary delivery
11/30/2005EP1599212A2 Combination therapy for the treatment of immunoinflammatory disorders
11/30/2005EP1599211A1 Use of rutin and isoharmnetin for treating depressive states and depression and other emotion disorders
11/30/2005EP1599210A1 A combined therapy comprising an indolopyrrolocarbazole derivative and another antitumor agent
11/30/2005EP1599209A2 Inhalation composition
11/30/2005EP1599208A2 Antiglucocorticoids for the treatment of postpartum psychosis
11/30/2005EP1599207A2 Treatment of excessive osteolyisis with indolinone compounds
11/30/2005EP1599206A2 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
11/30/2005EP1599205A1 Pten inhibitor or maxi-k channels opener
11/30/2005EP1599204A2 Selective mglu5 antagonists for treatment of neuromuscular dysfunction of the lower urinary tract
11/30/2005EP1599203A1 1,3-substituted cycloalkyl derivatives containing acidic, mainly heterocyclic groups, corresponding production method and use of said derivatives as medicaments
11/30/2005EP1599202A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/30/2005EP1599200A2 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
11/30/2005EP1599199A2 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist
11/30/2005EP1599198A1 Potassium taurate bicarbonate and ascorbate complexes
11/30/2005EP1599197A2 The use of antimuscarinic drugs
11/30/2005EP1599196A2 Combination therapies for the treatment of cancer
11/30/2005EP1599195A1 Use of non-immunosuppressive pipecolic acid derivatives for inducing chondrogenic differentiation
11/30/2005EP1599194A1 Use of active ingredients for the prophylaxis and/or therapy of viral diseases
11/30/2005EP1599193A2 Method for treating hypothyroidism
11/30/2005EP1599191A2 Pharmaceutical composition of alendronic acid, salts or esters thereof, and a process for its preparation
11/30/2005EP1599189A1 Control release formulation containing a hydrophobic material as the sustained release agent
11/30/2005EP1599187A2 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
11/30/2005EP1599183A2 Method of drug loading in liposomes by gradient
11/30/2005EP1599175A2 Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
11/30/2005EP1599174A2 Novel compounds
11/30/2005EP1599172A2 Methods for treatment of hiv or malaria using combinations of chloroquine and protease inhibitors
11/30/2005EP1599169A2 Method for increasing hair growth
11/30/2005EP1599096A2 Hetero substitued sodium channel blockers
11/30/2005EP1511385B1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
11/30/2005EP1467996B1 Pyrimidotriazines as phosphatase inhibitors
11/30/2005EP1465892A4 Glycinamides as factor xa inhibitors
11/30/2005EP1458381B1 Triazoles as oxytocin antagonists
11/30/2005EP1432708B1 Preparation and use of 1,5,6,7-tetrahydropyrrolo 3,2-c]pyridine derivatives for treatment of obesity
11/30/2005EP1406607B1 Verwendung einer antiviralen verbindungsklasse (dithiocarbamat-verbindungen) zur herstellung eines mittels zur behandlung bzw. pravention einer virusinfektion im respiratorischen trakt
11/30/2005EP1401839B9 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta [a] naphthalene
11/30/2005EP1392702B1 Compounds and methods for inhibiting mrp1
11/30/2005EP1392337B1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
11/30/2005EP1380295A4 Photosensitiser and method for production thereof
11/30/2005EP1363882A4 3-(3-amidinophenyl)-5- ( 1-(1-(-iminoethyl)-4-piperidyl amino)methyl]benzoic acid dihydrochloride and process for preparing the same
11/30/2005EP1353700B1 Compositions of estrogen-cyclodextrin complexes
11/30/2005EP1317483B1 Variants of allergenic proteins of the group 2 of dermatophagoides
11/30/2005EP1313740B1 Prodrugs of imidazopyridine derivatives
11/30/2005EP1313697B1 Immunoregulatory compounds, derivatives thereof and their use
11/30/2005EP1313511B1 Testosterone ester formulation for human use
11/30/2005EP1313488A4 Compositions and methods for improving cardiovascular function
11/30/2005EP1287005B1 Benzoic acid esters having antiplasmid effect
11/30/2005EP1278521B1 N-heterocyclic substituted salicylates for the treatment of cancer
11/30/2005EP1274457B1 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
11/30/2005EP1267831B1 New self emulsifying drug delivery system
11/30/2005EP1259485B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
11/30/2005EP1246668B1 An rapid acting freeze dired oral pharmaceutical composition for treating migraine
11/30/2005EP1224185B1 Thiazole and imidazo[4,5-b]pyridine compounds and their pharmaceutical use
11/30/2005EP1223985B1 Dialysis solution including polyglycol osmotic agent
11/30/2005EP1221941A4 Powder pharmaceutical formulations
11/30/2005EP1220612B1 Pediculocidal and veterinary compositions
11/30/2005EP1212314B1 Benzopyran derivative
11/30/2005EP1207809A4 Metering and packaging of controlled release medication
11/30/2005EP1194436B1 Sulfonamidomethyl phosphonate inhibitors of beta-lactamase
11/30/2005EP1185306B1 Use of viral vectors and charged molecules for gene therapy
11/30/2005EP1178793B1 Stable solid pharmaceutical compositions containing enalapril maleate
11/30/2005EP1173418B1 Crystalline form 3 of the sodium salt of 5- chloro -2- methoxy -n- (2- (4-methoxy -3- methyl aminothio carbonylamino sulfonylphenyl) ethyl) benzamide
11/30/2005EP1173153B1 Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
11/30/2005EP1169327B1 L-arabino-disaccharides of anthracyclines, processes for their preparation, and pharmaceutical compositions containing them
11/30/2005EP1159278B1 Inhibitors of aspartyl protease
11/30/2005EP1156796B1 Antithrombotic use of glycine betaine
11/30/2005EP1156787B1 Oxadiazole compounds and compositions for delivering active agents
11/30/2005EP1148883B1 Use of tricyclic antidepressants for treatment of headache
11/30/2005EP1146877B1 (2-imidazolin-2-ylamino) quinoxalines for the treatment of neural injury
11/30/2005EP1144372B1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
11/30/2005EP1140786B1 Reductive alkylation of secondary amines with hydrosilane
11/30/2005EP1140010B1 Composition and method of sequestration of skin irritants.
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005EP1089715B1 Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
11/30/2005EP1079832B1 Use of vitamin pp compounds
11/30/2005EP1071474B1 Substituted porphyrins
11/30/2005EP1049451B1 Use of compounds for protecting skin from uv induced immunosuppression
11/30/2005EP1003487B1 Pharmaceutical formulation with controlled release of active substances
11/30/2005EP0963200B9 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
11/30/2005EP0960121B1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
11/30/2005EP0932403B1 Condensed (hetaryl-substituted) 1-benzyl-3-pyrazol derivates for treating diseases of the cardiovascular and central nervous systems
11/30/2005EP0925291B1 Spirocyclic dopamine receptor subtype ligands
11/30/2005EP0920424B1 Non-peptide bombesin receptor antagonists
11/30/2005EP0891377B1 Inhibitor and stimulator of haematopoietic stem cell proliferation and uses thereof
11/30/2005EP0888341B1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives
11/30/2005EP0871631B1 Antiparasitic marcfortines and paraherquamides
11/30/2005EP0491793B1 2'-deoxy-4'-thioribonucleosides as antiviral and anticancer agents
11/30/2005CN1703619A Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
11/30/2005CN1703504A Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vivo$
11/30/2005CN1703442A Perfluoropolyether derivative
11/30/2005CN1703427A Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells
11/30/2005CN1703420A Promoters exhibiting endothelial cell specificity and methods of using same
11/30/2005CN1703416A Methods and compositions comprising nitric oxide donors and opioid analgesics
11/30/2005CN1703410A Isoquinoline compounds and medicinal use thereof
11/30/2005CN1703408A Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
11/30/2005CN1703406A Chirale oxazole-arylpropionic acid derivatives and their use as PPAR agonists
1 ... 4452 4453 4454 4455 4456 4457 4458 4459 4460 4461 4462 4463 4464 4465 4466 4467 4468 4469 4470 4471 4472 ... 7860